Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MKKGY

Recent news which mentions MKKGY

Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
Tickers MKKGY PFE SGEN
Tags MKKGY M&A General
From Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Tickers MKGAF MKKGY SNY
Tags Market News Benzinga MKGAF
From Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Tickers MKGAF MKKGY RGEN
Tags RGEN News Briefs
From Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Tickers MKGAF MKKGY
Tags Benzinga MKGAF Guidance
From Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Tickers MKGAF MKKGY NVO REGN
Tags RHHBF RHHVF Briefs
From Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Tickers A ABCM DHR MKGAF
Tags Expert Ideas Analyst Color ABCM
From Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Tickers LLY MKGAF MKKGY NKTR
Tags Biotech NKTR Health Care
From Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Tickers MKGAF MKKGY
Tags MKKGY General Briefs
From Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Tickers M MKGAF MKKGY PFE
Tags General MKKGY News
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags Health Care MGNX Biotech
From Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Tickers MKKGY MRSN
Tags Small Cap Biotech Health Care
From Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Tickers MKGAF MKKGY PDSB
Tags News Briefs Movers
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Tickers MKGAF MKKGY MRSN
Tags MKKGY General Briefs
From Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Tickers AAPL ABT ACI AMZN
Tags Earnings AMZN M&A
From Benzinga
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
Tickers MKKGY
Tags Market News Benzinga News
From Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
Tickers MKKGY MRK PDSB
Tags PDSB MKKGY General
From Benzinga
Here's How Day One Biopharmaceuticals Stock Could Keep Climbing
Tickers DAWN MKKGY
Tags Market News ^IXIC MKKGY
From Motley Fool
Germany's Merck To Launch Semiconductor Base In China
Tickers MKKGY TECH
Tags MKKGY News Briefs
From Benzinga
Wall Street Thinks Palantir Is Poised for a Comeback. Here's Why
Tickers MKKGY PIPR PLTR
Tags PIPR Market News PLTR
From Motley Fool
Cathie Wood Can't Get Enough of These 2 Biotech Stocks
Tickers ADPT ARKG BNR MKKGY
Tags ARKG ADPT Recent Press Releases
From Motley Fool
TSM Looks To Hire Over 8,000 People In 2022
Tickers ASML ENTG MDTKF MKKGY
Tags TSM Benzinga ENTG
From Benzinga
Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing
Tickers MKKGY PLTR
Tags PLTR Market News Stocks to Sell
From InvestorPlace
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Tickers AZN BNR BNTX CBAY
Tags BNTX ITMR CBAY
From Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Tickers GSK MKGAF MKKGY MRK
Tags News Briefs GSK
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Tickers MKGAF MKKGY NKTR PFE
Tags Market News PFE MKGAF
From Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Tickers GSK MKGAF MKKGY MRK
Tags Briefs News GSK
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.